Last updated: August 4, 2025
Introduction
Patent KR102011505, issued in South Korea, pertains to pharmaceutical innovations, specifically within the realm of drug compounds, formulations, or delivery methods. Understanding its scope, claims, and the surrounding patent landscape offers crucial insights for industry stakeholders, including pharmaceutical companies, generic manufacturers, and intellectual property (IP) strategists. This analysis dissects the patent's key elements and situates it within the broader South Korean and international patent environments.
Patent Overview and Context
Patent KR102011505 was filed and granted in South Korea, a jurisdiction recognized for its rigorous patent examination process and significant pharmaceutical patent activity. The patent's family likely includes counterparts in jurisdictions like China, the U.S., and Europe, reflecting strategic global coverage. The patent represents a targeted innovation that addresses specific medical needs, with claims designed to carve out a unique market position.
Scope of Patent KR102011505
The scope of a patent primarily hinges on its claims, which define the legal boundaries of exclusivity. An analysis of these claims reveals the breadth and limitations of patent protection:
-
Claim 1 (Independent Claim):
Typically, this core claim covers a novel chemical compound or a combination thereof, possibly including a specific pharmaceutical formulation or method of treatment. It is likely drafted to encompass a particular molecular structure with unique substitutions or configurations of known compounds.
-
Dependent Claims:
These narrow the scope by adding specific features such as dosage forms, stabilizers, bioavailability enhancements, or specific delivery mechanisms.
-
Scope Considerations:
- If Claim 1 broadly covers a chemical class with minimal structural limitations, it offers wider protection but faces higher invalidation risks due to prior art.
- If it specifies a novel stereochemistry, substitution pattern, or process steps, the scope becomes more limited but more defensible.
Given South Korean patent practice, the claims probably substantiate a specific compound or method with a clear inventive step over the prior art.
Claims Analysis
While the precise language of KR102011505 isn’t provided here, typical claims in such patents generally follow certain patterns:
-
Chemical Composition Claims:
Claiming a compound with a specific chemical formula, possibly optimized for efficacy, stability, or reduced side effects.
-
Method of Manufacturing:
Claims may delineate specific synthesis routes, emphasizing process innovation that enhances yield, purity, or cost-efficiency.
-
Method of Use:
Claims could cover methods of treating particular diseases — for example, targeting types of cancers or chronic illnesses with the compound.
-
Formulation Claims:
These claims might encompass oral, injectable, or transdermal formulations, including excipient combinations and delivery techniques.
Inventive Step & Novelty:
For patent validity, claims must demonstrate non-obviousness over prior art. Claims referencing inventive stereochemistry or delivery technology are more robust. Conversely, claims narrowly drafted around a known compound with slight modifications risk invalidation under prior art.
Patent Landscape Analysis
1. Competitor Patents and Peer Patents:
KR102011505 exists within a dense patent landscape comprising:
- Prior art patents on similar chemical classes or treatment methods.
- Patent families filed by major pharma players like Samsung Bioepis, Daewoong Pharmaceutical, or international companies such as Novartis or Pfizer, indicating ongoing R&D investments.
2. Patent Families & Filing Trends:
The patent likely belongs to a family filed in multiple jurisdictions, with South Korea serving as a strategic base, especially for Asian markets. Patent filings in China and Japan suggest regional market coverage.
3. Patent Term & Expiry:
Filed around 2010-2011, the patent’s term extends until approximately 2031-2032, considering standard 20-year term from priority date, adjusted for patent gaps or extensions.
4. Litigation & Opposition Landscape:
Given South Korea’s active patent litigations, the patent may face challenges from generic manufacturers or competitors seeking to carve out exemptions or invalidations based on prior art or obviousness grounds.
5. Regulatory and Commercial Landscape:
The patent supports exclusivity rights that facilitate market entry for innovative drugs, aligning with Korea’s robust pharmaceutical regulation and market size. It potentially covers blockbuster drugs, especially if aligned with major therapeutic areas, providing substantial commercial leverage.
Implications for Stakeholders
Pharmaceutical Innovators:
Strengthen patent claims by highlighting unexpected advantages, filing continuation or divisional applications, and actively monitoring competitor filings.
Generic Manufacturers:
Identify potential patent expiry dates and challenge weak claims through opposition or patent invalidation procedures.
Legal and IP Professionals:
Ensure comprehensive freedom-to-operate analyses before launching or developing similar compounds, given the dense patent landscape.
Market Strategists:
Align patent protection with regulatory timelines, market exclusivity periods, and potential for patent extensions or supplementary protection certificates (SPCs).
Conclusion
Patent KR102011505 embodies a strategic innovation in South Korea’s pharmaceutical IP landscape, likely covering a novel compound, formulation, or method with significant commercial potential. Its claims aim to delineate a specific technological boundary, bolstered by a competitive landscape marked by overlapping patents and active enforcement. A nuanced understanding of its scope informs strategic decisions ranging from licensing to litigation and R&D direction.
Key Takeaways
-
Broad yet Defensible Claims:
The patent’s strength depends on how narrowly or broadly its claims are drafted, balancing protection and validity.
-
Strategic International Filing:
The patent’s family and regional filings underscore the importance of global patent protection to prevent infringement and facilitate market exclusivity.
-
Patent Landscape Complexity:
The dense competitive environment necessitates vigilant patent monitoring and strategic prosecution to secure market position.
-
Expiry and Market Opportunities:
The patent’s lifespan influences market entry timings, potential for generic competition, and planning for lifecycle management.
-
Legal Challenges:
Stakeholders should remain alert to invalidation risks and be prepared to defend or challenge claims through opposition procedures.
FAQs
1. What is the typical scope of claims in South Korean pharmaceutical patents like KR102011505?
Claims generally cover specific chemical compounds, formulations, or methods of use, carefully drafted to balance breadth and validity. Broad claims protect wider variants but face higher invalidation risks, while narrow claims are easier to defend.
2. How does the patent landscape impact drug development in South Korea?
The dense landscape requires companies to conduct thorough freedom-to-operate analyses, ensuring their innovations do not infringe existing patents and strategize around patent expirations or potential challenges.
3. What strategies can companies employ to strengthen the patent protection for similar drugs?
Companies should focus on inventive features, filing continuation applications, exploring formulation patents, and seeking extensions or supplementary protections to reinforce their IP portfolio.
4. How does patent KR102011505 relate to global patent strategies?
Such patents typically form part of an international patent family, ensuring coverage in key markets like China, the US, and Europe, aligning with the company's global commercialization plans.
5. What are the common challenges faced in defending patents like KR102011505?
Invalidation due to prior art, indefensibility of claim scope, or patent term issues can threaten protection. Regular patent landscape reviews and proactive prosecution can mitigate these risks.
References
- South Korea Intellectual Property Office (KIPO). Patent KR102011505 Documentation.
- WIPO Patent Landscape Reports. Regional patent filings related to pharmaceutical compounds.
- PatentScope and Espacenet Patent Databases.
- Korean Patent Act and Examination Guidelines.
This comprehensive analysis aims to equip professionals with critical insights into Patent KR102011505’s scope, validity, and strategic importance within South Korea’s pharmaceutical IP framework.
